Table 1.
Patient No. | Sex | Age of Onset | Clinical Features |
Genotypes |
Unusual Phenotypes | ||||
---|---|---|---|---|---|---|---|---|---|
P | H | SW | HH | DNA Mutation | Protein Change | ||||
I | M | 1 mo | X | X | X | X | c.805_807delGTC | p.Val269del | — |
II | M | 2 d | X | X | X | N/A | c.805_807delGTC | p.Val269del | — |
III | M | 24 d | X | X | X | N/A | c.1148_1149delGG | p.Gly383Aspfs*5 | — |
IV | M | 17 y | X | - | — | X | c.1156C>T | p.Leu386Phe | Late-onset Addison |
V | M | 1 mo | X | — | X | N/A | c.363delG | p.Gly122Valfs*142 | Precocious puberty |
VI | M | 3.5 y | X | — | X | X | c.1062delC | p.Ala355Profs*17 | — |
VII | M | 3 d | X | X | X | X | c.501_502insG | p.Ala170Argfs*15 | Growth hormone deficiency |
Novel mutations are indicated in bold.
Abbreviations: H, hypoglycemia; HH, hypogonadotropic hypogonadism; N/A, not applicable; P, hyperpigmentation; SW, salt-wasting.